Used as a selective p38 MAP kinase inhibitor in research settings to study inflammatory pathways. Helps in evaluating the role of p38 signaling in cellular responses such as cytokine production, stress responses, and apoptosis. Commonly applied in preclinical studies to assess potential therapeutic effects in models of inflammation, autoimmune diseases, and neurodegenerative conditions. Also utilized in pharmacological assays to determine kinase inhibition potency and selectivity profiles.